Survival role of protein kinase C (PKC) in chronic lymphocytic leukemia and determination of isoform expression pattern and genes altered by PKC inhibition

Serhan Alkan(Cedars-Sinai Medical Center), Keith F. Izban(Loyola University Medical Center), Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region), Gladell P. Paner(University Health Network), Mitchell F. Denning, Melek Ergin(Loyola University Medical Center), Fulya Öz Puyan(Loyola University Medical Center), Sucha Nand(Loyola University Medical Center), Tazeen Maududi(Loyola University Medical Center)

American Journal of Hematology

May 31, 2005

10.1002/ajh.20352

Cited by 35

Related Papers

The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma

|The American Journal of Surgical Pathology|2020|705

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

|Blood|2013|683

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

|Blood|2012|396

Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver.

|Journal of Biological Chemistry|1993|375

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

|Leukemia|2012|362